Massachusetts Society of Clinical Oncologists - The Centers for Medicare and Medicaid Services (CMS) has issued a J-code for enfortumab-vedotin ejfv (Padcev)

"The voice for cancer physicians and their patients in Massachusetts."

Home
Resources
Protocols Listing
The Centers for Medicare and Medicaid Services (CMS) has issued a J-code for enfortumab-vedotin ejfv (Padcev)

The Centers for Medicare and Medicaid Services (CMS) has issued a J-code for enfortumab-vedotin ejfv (Padcev)

01 Jul 2020 7:04 AM | Nathan Strunk

The Centers for Medicare & Medicaid Services (CMS) released the July 2020 Quarterly Healthcare Common Procedural Coding System (HCPCS) File, which includes the designation of J9177 for PADCEV with the effective date of July 1, 2020.

Massachusetts Society of Clinical Oncologists (c)

P.O. Box 549154, Waltham, MA, 02451
t: 781.434.7329 | f: 781.464.4896 |email: msco@mms.org